Skip to content

Clinical trials

Phase 3 Small Cell Lung Carcinoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 3 Country / region: Canada Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20071
20111
20121
20161
20173
20182
20202
20213
20222
20231
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting7
Recruiting5
Terminated3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
Merck Sharp & Dohme LLC3
Alliance for Clinical Trials in Oncology2
Amgen2
AstraZeneca2
Bristol-Myers Squibb2
GlaxoSmithKline2
NRG Oncology2
PharmaMar2
Alaunos Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma27
Lung Neoplasms9
Carcinoma, Non-Small-Cell Lung3
Brain Neoplasms2
Breast Neoplasms2
Neoplasm Metastasis2
Neoplasms2
Carcinoma1
Carcinoma, Renal Cell1
Carcinoma, Small Cell1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.